Clinical Trials Logo

Filter by:
NCT ID: NCT06164028 Recruiting - Acute Pain Clinical Trials

COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children

COA-APTIC
Start date: August 15, 2023
Phase:
Study type: Observational

Evaluate the content validity and comprehensibility of a caregiver observer-reported outcome assessment and clinician-reported assessments for acute pain in children aged 0 to <2 years. The primary objective of the Qualitative Protocol in the UH3 phase study is to establish or create reliable Clinical Outcome Assessments (COAs) and endpoints that can assess acute pain during clinical trials of pain therapeutics specifically designed for infants and young children (0 - <2 years).

NCT ID: NCT06163898 Active, not recruiting - Multiple Myeloma Clinical Trials

A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Start date: February 27, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the recommended dose and schedule, and evaluate the safety and preliminary efficacy of alnuctamab in combination with mezigdomide in participants with relapsed and/or refractory multiple myeloma.

NCT ID: NCT06163703 Recruiting - Parenting Clinical Trials

Strengthening Child Social-Emotional and Lifestyle Health in Families Experiencing Stress

Start date: February 9, 2024
Phase: N/A
Study type: Interventional

This study evaluates feasibility and preliminary efficacy of a parent-based prevention program to promote social-emotional and lifestyle behavior health among 3- to 9-year-old children in families experiencing major stressors.

NCT ID: NCT06163690 Recruiting - Long COVID Clinical Trials

Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops

Start date: December 13, 2023
Phase:
Study type: Observational

This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Participants 21 and older will take Formula C™ for 90 days. During that time, participants will answer weekly surveys to track symptoms and wellbeing.

NCT ID: NCT06163599 Not yet recruiting - Anxiety Disorders Clinical Trials

Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The primary aim of our study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs.

NCT ID: NCT06163586 Recruiting - Massage Therapy Clinical Trials

Infant Massage in the NICU

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the effects of Neonatal Touch and Massage Therapy on premature babies. The main questions it aims to answer are: - Do babies who receive Neonatal Touch and Massage Therapy get discharged sooner from the NICU - Does Neonatal Touch and Massage Therapy have a beneficial effect on weight gain, pain and stress responses, and neurodevelopmental outcomes. Participants assigned to the treatment group will receive Neonatal Touch and Massage Therapy while admitted to the NICU. Researchers will compare their outcomes to a control group, receiving standard NICU care, to see if there are any differences in the length of hospital stay, weight gain, pain scores, neurodevelopmental outcomes, and incidence of other common conditions associated with prematurity.

NCT ID: NCT06163534 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Start date: May 2024
Phase:
Study type: Observational [Patient Registry]

The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.

NCT ID: NCT06163508 Enrolling by invitation - Transverse Myelitis Clinical Trials

A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells

Start date: December 12, 2023
Phase:
Study type: Observational

This study is an observational study designed to obtain information on the long-term safety, tolerability, and continued activity of Q-Cells®. The study will follow the participants who previously received Q-Cells® for 10 years. The goal of this observational study is to learn about the long term effects of Q-Cells® in people with transverse myelitis. The main objectives the study is to evaluate the safety of patients who have received Q-Cells®. The secondary goal of the study is to get data about the long-term activity of Q-Cells® over a period of 10 years. Patients will complete exams, lab tests, imaging, and questionnaires to monitor their safety.

NCT ID: NCT06163482 Recruiting - Cystic Fibrosis Clinical Trials

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

Start date: March 28, 2023
Phase:
Study type: Observational

In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.

NCT ID: NCT06163469 Recruiting - Urinary Retention Clinical Trials

Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the feasibility and tolerability of 0.05% Chlorhexidine Gluconate (CGH) bladder instillations in an outpatient setting at the time of suprapubic catheter (SPC) exchange in patients with history of recurrent urinary tract infections (UTI). The main questions are: 1. is instillation of 150mL of CGH for five-minute duration at the time of SPC exchange feasible in an outpatient setting and tolerable for patients. 2. does this protocol decrease the rate of unplanned health care visits and improve patient quality of life. Patients will undergo the treatment protocol during their routine suprapubic catheter exchanges.